(Q44790188)

6 December 2017

0 references

Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? (English)

1 reference

chronic renal insufficiency

6 December 2017

1 reference

1 reference

Peter A McCullough

1

1 reference

PubMed ID

12628713

6 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of the American College of Cardiology

6 December 2017

1 reference

6 December 2017

41

1 reference

6 December 2017

5

1 reference

6 December 2017

725-728

1 reference

Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Risks associated with renal dysfunction in patients in the coronary care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Preoperative renal risk stratification.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902955-8

7 January 2021

10.1016/S0735-1097(02)02955-8

Identifiers

DOI

1 reference

6 December 2017

1 reference

PubMed ID

12628713